Share on PinterestVaccine vials hanging at the Cruise Centre Steinwerder vaccination centre in Hamburg. Daniel Bockwoldt/photograph alliance through Getty
The Moderna and Pfizer vaccines have been really effective at protecting against COVID-19.
In a new research, researchers seemed at the dissimilarities in performance in between the two vaccines.
They uncovered that persons who experienced gained two doses of the Moderna vaccine ended up fewer likely to create COVID-19 or turn into hospitalized with the illness than men and women who experienced obtained the Pfizer vaccine.
Both the Moderna and Pfizer COVID-19 vaccines are messenger ribonucleic acid (mRNA) vaccines — a rather new sort of vaccine engineering.
These COVID-19 vaccines function by supplying our cells with directions for producing a SARS-CoV-2 protein. Our immune program then reacts to these proteins and develops the resources to respond to any infection with the virus in the upcoming.
Experts from the Facilities for Disorder Manage and Prevention (CDC) have observed that both the Moderna and Pfizer vaccines are pretty helpful at shielding folks from COVID-19.
CDC Director Dr. Rochelle P. Walensky factors to “accumulating proof that mRNA COVID-19 vaccines are effective and must stop most bacterial infections.” She provides that “Fully vaccinated people today who continue to get COVID-19 are most likely to have milder, shorter sickness and appear to be considerably less most likely to distribute the virus to some others.”
“These benefits are a further essential reason to get vaccinated.”
In the hottest research, scientists investigated the distinctions in fees of “breakthrough” conditions of COVID-19 between individuals who acquired the Moderna or Pfizer vaccines. A breakthrough situation is when the ailment develops in an individual who has been fully vaccinated against it.
The team was also intrigued in any variances between costs of hospitalization and demise owing to COVID-19 between people today who obtained either vaccine.
For their analysis, the researchers drew on health documents from 89 million men and women in the United States. The data incorporated people with a broad selection of demographic attributes.
The crew appeared at knowledge taken concerning July and November 2021, when the Delta variant of COVID-19 was the main variant of the virus.
The final results seem as a investigate letter in JAMA.
The researchers observed that in November 2021, there had been 2.8 breakthrough circumstances of COVID-19 in people absolutely vaccinated with the Pfizer vaccine for each 1,000 men and women. They involved breakthrough situations if the folks experienced not gained the booster vaccination or experienced not experienced a prior recorded infection with SARS-CoV-2.
For the Moderna vaccine, the monthly figure was substantially lessen, at 1.6 breakthrough situations for each 1,000 people who received these pictures.
The hazard of hospitalization in the 60 days following an infection was also reduce for folks thoroughly vaccinated with the Moderna vaccine: 12.7{cfdf3f5372635aeb15fd3e2aecc7cb5d7150695e02bd72e0a44f1581164ad809} for Moderna as opposed to 13.3{cfdf3f5372635aeb15fd3e2aecc7cb5d7150695e02bd72e0a44f1581164ad809} for Pfizer.
The researchers did not see a important variance in mortality costs concerning the two vaccine teams.
Healthcare News These days spoke with Dr. Rong Xu, a professor of biomedical informatics at Situation Western Reserve University’s College of Drugs and the corresponding writer of the new research.
Dr. Xu pointed out, “We in comparison recipients of these two vaccines although accounting for individual hazard elements, distinct approval time, and varying time from vaccination.”
“I believe that inherent change in these two vaccines may perhaps have partially accounted for the noticed big difference in equally breakthrough infection and hospitalization.”
Dr. Xu thought that both vaccines would carry on to be productive from the Omicron variant of SARS-CoV-2.
“My speculation is that we can hope that vaccines are helpful against extreme clinical results linked with Omicron variant bacterial infections, as research showed that vaccines can elicit T cell immunity, which might give safety towards Omicron. We will carry out a identical analyze for [SARS-CoV-2] an infection with Omicron,” Dr. Xu claimed.
Dr. Pamela B. Davis, the Arline and Curtis Garvin investigation professor at the Heart for Local community Wellbeing Integration and a co-creator of the study, highlights that “Although there is a big difference in breakthrough infections, each vaccines are really protecting versus SARS-CoV-2 an infection and primarily in opposition to the most intense penalties of infection.”
“Further scientific studies are essential to assess the effects of booster doses and also the protection afforded particularly vulnerable populations by vaccines.”
For dwell updates on the newest developments regarding COVID-19, click on below.
A new version of the Omicron variant of SARS-CoV-2, known as BA.2, has emerged. Although experts are unsure about its effects, they know that it is spreading quickly and has 20 mutations in the area that most COVID-19 vaccines target.
Share on PinterestShould we be worried about the ‘stealth variant’ of Omicron? Image credit: Kate Geraghty/The Sydney Morning Herald via Getty Images.
Scientists first identified the BA.2 subvariant of Omicron in India and South Africa in late December 2021. Since then, it has spread to several countries, including the United States, the United Kingdom, and Israel.
The subvariant virus has also spread rapidly in Denmark, increasing from 20{cfdf3f5372635aeb15fd3e2aecc7cb5d7150695e02bd72e0a44f1581164ad809} of all COVID-19 cases in the country in week 52 of 2021 to 45{cfdf3f5372635aeb15fd3e2aecc7cb5d7150695e02bd72e0a44f1581164ad809} in the second week of 2022.
Despite its rapid spread in the country, initial analyses show no difference in hospitalizations between the BA.2 subvariant and the original form of Omicron, also known as BA.1.
Studies, however, are still ongoing to understand the infectiousness of BA.2, alongside how effective vaccines are against it.
While BA.2 is not currently a “variant of concern,” public health officials in the U.K. have taken enough interest in its spread to designate it as a “variant under investigation.”
To understand more about the emerging subvariant, Medical News Today spoke with six experts in public health, immunology, and infectious diseases.
“Omicron has three main [subvariants] — BA.1, BA.2, and BA.3 — according to the World Health Organization (WHO),” Dr. Donald C. Vinh, associate professor in the Department of Medicine at McGill University, Canada, told MNT.
“Up until now, the overwhelmingly large majority of all Omicron cases has been BA.1. However, in some places, the BA.2 has emerged and has spread faster than BA.1,” he went on to note.
“This sister variant, which is still Omicron, is interesting because it seems to be displacing Omicron in certain parts of the world,“ Dr. Amesh A. Adalja, senior scholar at Johns Hopkins Center for Health Security, told MNT. “There is speculation that it may be more transmissible than its sibling.”
How the fast spread of the BA.2 subvariant may affect public health is still under investigation.
“The Omicron SARS-CoV-2 variant has been interesting to scientists because of its comparatively (i) higher number of mutations, which […] allow it to partially evade people’s immune response; (ii) higher transmissibility and pathogenicity, i.e., its greater ability to infect and cause disease; and (iii) lower virulence, i.e., its lower ability to cause severe disease,” Dr. Richard Reithinger, Ph.D., vice president of global health at RTI International, explained.
“The big question for newly identified variants and subvariants such as omicron BA.2 is how these above three characteristics vary from the original SARS-CoV-2 virus [variant] or the Omicron variant and why.”
– Dr. Richard Reithinger, Ph.D.
“If some countries are now reporting a surge in the proportion of BA.2 subvariant infections, is it because the additional mutations make it more transmissible or allow it to evade the immune response more easily than the other Omicron subvariants? Will BA.2 result in the same clinical pathology as the Omicron parent variant (B.1.1.529) and subvariants (BA.1 and BA.3)? Also, how do current therapeutic options and vaccines fare against BA.2?”
According to Dr. Reithinger, these are some of the questions that public health experts must take into consideration while keeping this subvariant under observation.
While researchers are still gathering data on how BA.2 may affect the population at large, laboratory studies have already verified many of its molecular properties.
“BA.2 is missing the spike 69-70 mutations, so it does not cause S gene target failure, making it harder to identify on PCR tests,” Dr. Anna Ssentongo, assistant professor of public health at the Penn State College of Medicine, told MNT.
“Because of this, BA.2 was nicknamed the ‘stealth variant,’” she explained.
Dr. Ssentongo added that BA.2 has more than 20 mutations in its spike protein, which is a target of many COVID-19 vaccines because the virus uses it to enter healthy cells. Although this difference may make BA.2 more resistant to vaccines, further research is necessary to confirm any effects.
“Similar to its parental lineage (Omicron), it is expected to be highly transmissible and result in less severe disease than the Delta or Beta variants, especially if one is fully vaccinated and — even better — boosted,” added Dr. Reithinger. “However, ultimately, this would have to be confirmed by ongoing laboratory and clinical studies, which are expected to provide results in the next couple of weeks.”
Dr. Vinh agreed that before drawing any conclusions on how the subvariant may affect public health, further research is necessary:
“It is important to mention that there are very limited data on clinical differences between BA.2 and BA.1. Specifically, we have no firm data to know if BA.2 is more contagious, results in more severe disease, or can evade immunity better than BA.1. Nonetheless, early data from Denmark and the U.K. suggest that BA.2 may be more contagious than BA.1.”
When MNT asked whether we should be concerned about BA.2, Dr. Pavitra Roychoudhury, research associate at the Vaccine and Infectious Disease Division at the University of Washington, explained: “It remains to be seen how BA.2 will compete against currently circulating viruses […], and also whether it causes more severe disease. […] We will continue to monitor frequencies of BA.2 through the use of genomic surveillance.”
Dr. Adalja agreed that much remains to be seen: “We know that this has been a variant that has been present since the early days of Omicron and that it has some similar and some distinct mutations. It is unclear, as of now, whether it is more transmissible. [It] likely has the same characteristics when it comes to vaccine efficacy and severity.”
“It is too early to know what role [BA.2] may play. It’s likely that it will just be part of the Omicron wave and they extend it over time and eventually become the dominant version of Omicron. More study is needed.”
– Dr. Amesh Adalja
However, Dr. Barton F. Haynes, director of the human vaccine institute in the Department of Medicine at the Duke University School of Medicine, said that due to its molecular changes, there might be cause for concern regarding BA.2.
“We are worried that because it is so different than Omicron BA.1, it may escape current vaccines and Omicron BA.1-neutralizing antibodies,” he noted. “To this point, we are working to study the Omicron BA-2 virus to see whether current vaccine-induced neutralizing antibodies neutralize it.”
“Whether BA.2, or any other Omicron subvariant or other SARS-CoV-2 variant, there is irrefutable evidence that existing vaccines are quite effective in protecting people against infection and highly effective in protecting people from developing severe disease or — worst case scenario — dying upon SARS-CoV-2 infection,” explained Dr. Reithinger.
“Additionally, even if vaccinated, people should consider adhering to nonpharmaceutical interventions, such as face masks, physical distancing, and handwashing, particularly when in crowded and/or high transmission environments,” he advised.
For live updates on the latest developments regarding COVID-19, click here.
Share on PinterestHumber River Hospital’s Intensive Care Unit, in Toronto, Canada, on April 28, 2020. COLE BURSTON/Getty Images
An observational study examined data from around 34,000 physicians in Ottawa, Canada.
Researchers found physicians participated in nearly 26{cfdf3f5372635aeb15fd3e2aecc7cb5d7150695e02bd72e0a44f1581164ad809} more mental health and substance use visits during the first year of the COVID-19 pandemic compared to the year prior.
The study team believes the increase is attributable to both increased stressors during the pandemic and additional access to mental health services through virtual outpatient options.
There is no denying the fact the COVID-19 pandemic has had an impact on the mental health of people worldwide. A recent study found the pandemic increased cases of major depressive disorder by 53 million and anxiety disorders by 76 million globally.
But for those working on the front lines of the pandemic — such as healthcare workers — how has the situation affected their mental health?
A team of researchers from the University of Ottawa Department of Family Medicine and The Ottawa Hospital in Canada is helping answer that question. Their new study has found a link between the pandemic and the number of outpatient healthcare visits physicians participated in for mental health and substance use concerns.
Researchers believe their study results will help shed light on the need for increased mental health services for the medical community.
The results from this population-based cohort study appear in JAMA Open Network.
Before the COVID-19 pandemic, studies showed an elevated rate of mental health issues among healthcare workers. One such study in 2015 found resident physicians were at high risk for depression. Another study in 2018 examined burnout among United States healthcare professionals, finding over one-half of physicians and one-third of nurses had symptoms affecting their mental health.
Interestingly, other studies have linked higher levels of substance misuse issues to healthcare professionals. According to American Addiction Centers, approximately 4.4{cfdf3f5372635aeb15fd3e2aecc7cb5d7150695e02bd72e0a44f1581164ad809} of medical workers have a problem with heavy alcohol consumption. And about 5.5{cfdf3f5372635aeb15fd3e2aecc7cb5d7150695e02bd72e0a44f1581164ad809} of healthcare personnel experience illicit drug use.
Dr. Daniel Myran, a family physician, public health and preventive medicine specialist, and postdoctoral fellow at the University of Ottawa Department of Family Medicine and The Ottawa Hospital, is the lead author of this current study.
According to him, multiple surveys have found high levels of mental distress in healthcare workers, including physicians, during the COVID-19 pandemic.
“However, because these surveys generally look at one or two points in time, it limits our understanding of whether these concerning rates of mental distress reflect a worsening during COVID-19 or reflect pre-pandemic baselines,” Dr. Myran told Medical News Today. “In addition, most surveys have low response rates, which raises concerns that their results may not represent the overall mental health of physicians.”
The team addressed this by taking an alternative approach, looking at changes in mental health care-related visits that physicians made during the pandemic. “Because we were able to follow mental health visits before and during the pandemic, we were able to quantify how visits changed over time,” Dr. Myran explained.
Dr. Myran and his team conducted a population-based cohort study of 34,055 physicians, fellows, and residents registered with the College of Physicians and Surgeons of Ontario between 1990 and 2018. All study participants were eligible for the Ontario Health Insurance Plan. The researchers collected the data from the Ontario Health Insurance Plan from March 2017 to March 2021.
During the study, researchers examined all in-person and virtual outpatient visits via telemedicine to either a psychiatrist or primary care physician. Researchers considered all psychiatry visits mental health or substance use-related medical visits. In their study, the team also included any visits to a primary care physician that included a diagnostic or fee code related to mental health or substance use.
The research team also investigated specific demographic characteristics, including:
age
sex
residence, whether urban or rural
previous mental health history
According to the study, data on race and ethnicity was not available. And the researchers also looked at the data by physician specialty to see if a specific area of the healthcare industry was more prone to mental health concerns.
According to the study results, physicians participated in 29,460 mental health visits during the first year of the COVID-19 pandemic.
This is almost a 26{cfdf3f5372635aeb15fd3e2aecc7cb5d7150695e02bd72e0a44f1581164ad809} increase compared to the 23,574 mental health care visits physicians made the year prior.
When looking at mental health visits, researchers found anxiety was a frequent cause in both the first year of COVID-19 and the year before. Indeed, anxiety visit frequency increased during the first year of COVID-19 from 66.5{cfdf3f5372635aeb15fd3e2aecc7cb5d7150695e02bd72e0a44f1581164ad809} to 69.1{cfdf3f5372635aeb15fd3e2aecc7cb5d7150695e02bd72e0a44f1581164ad809}.
Researchers found that drug and alcohol-related visits saw a slight decline to 5.8{cfdf3f5372635aeb15fd3e2aecc7cb5d7150695e02bd72e0a44f1581164ad809} during the first year of COVID-19 from 7.4{cfdf3f5372635aeb15fd3e2aecc7cb5d7150695e02bd72e0a44f1581164ad809} the year before.
When looking at demographic information, researchers reported female medical professionals and healthcare workers in urban areas had a larger percentage of mental health and substance use visits. And among physician specialties, psychiatrists had the highest number of mental health care visits during the first year of COVID-19, while surgeons had the lowest.
The research team also reported that physicians without a history of mental health issues or substance misuse had the largest increase in the rate of visits compared to physicians with such a history. “This finding may reflect how the pandemic created new and highly stressful challenges for physicians,” Dr. Myran explained.
“These challenges may have caused a deterioration in the mental health of doctors who otherwise never would have needed care.”
“Another possibility is that changes in how health services were offered during COVID-19 — offering virtual mental health care — decreased important barriers to access for some physicians who used this opportunity to seek care for preexisting mental health concerns that they had never sought treatment for before,” Dr. Myran added.
In general, Dr. Myran believes the increased access to virtual options through telemedicine may partially explain the overall increase in mental health visits during the COVID-19 pandemic. “Physicians with mental health concerns that pre-dated COVID-19 may have used these services during the pandemic, as they were more accessible and less visible, reducing concerns over stigma,” he said.
Dr. Myran feels this research helps support the continuation of virtual mental health and substance use medical care for healthcare workers.
“While we suspect that much of the increase in visits during the pandemic is related to increased stressors and challenges, some of this increase may be related to better mental health access and reduced stigma.”
– Dr. Myran
“Ongoing access to virtual care services may be an important component of a post-pandemic mental health strategy aimed at improving the mental health of physicians and health care workers.”
Dr. Ken Duckworth, chief medical officer of the National Alliance on Mental Illness (NAMI), agrees. “It doesn’t surprise me that doctors are taking advantage of (teletherapy) — there’s probably no time in the middle of a busy day to see a mental health practitioner,” he told MNT.
“The pandemic represented this tremendous switch being flipped towards the understanding that teletherapy is a safe way to deliver effective care. Teletherapy is the silver lining to this really dark cloud we’re dealing with.”
Dr. Duckworth views this study’s findings as positive, as they show a change in the “old school” mentality that doctors would ever need or require help. “The idea of physicians accepting help, discussing their vulnerabilities, taking care of themselves under stress, so they can take good care of other people is to me, a very positive development,” he said.
“The stressors of the pandemic are clear — they impact anybody who’s in a frontline role. I would be very distressed if the finding was that physicians in the context of the pandemic were not seeking mental health and addiction support.”
As for the next steps, Dr. Myran plans to look at the time after the start of the COVID-19 pandemic. “Our study only looked at the first year of the pandemic, but the situation now is very different than it was a year ago,” he said.
“We plan on continuing to understand the longer-term changes in mental health visits in physicians during the pandemic. We are also interested in understanding predictors of mental health care use by physicians so that services and interventions can be better targeted to meet physician needs.”
Dr. Duckworth added he would like to see a study of this type conducted for United States physicians. And for frontline workers seeking mental health resources, he suggests visiting the Frontline Wellness section of NAMI’s website for free, confidential resources for all frontline workers, including healthcare professionals.
Share on PinterestUpdated data from the American Heart Association (AHA) emphasize the crucial link between heart and brain health. Image credit: Hiroshi Watanabe/Getty Images.
The 2022 Update of the AHA’s Heart Disease and Stroke Statistics emphasizes the bidirectional relationship between brain and heart health.
Globally, the number of dementia cases and deaths has increased alarmingly over the past 3 decades, more than heart disease.
Modifying risk factors for cardiovascular disease, such as smoking, diabetes, high blood pressure, obesity, and high cholesterol, may promote healthy aging and prevent cognitive decline.
Current evidence suggests a robust connection between brain health and cardiovascular health. Damage to the heart and blood vessels can increase a person’s risk of stroke and dementia.
A stroke occurs when a clot blocks blood flow or when a blood vessel ruptures in the brain. Strokes cause the death of brain tissue, sometimes resulting in a decline in memory and profound disability.
Additionally, the cumulative effect of multiple small silent strokes — which health experts call ministrokes — can cause vascular dementia. Dementia can have a detrimental impact on memory, cognitive functioning, and personality.
The AHA and the National Institutes of Health (NIH) update vital heart disease and stroke statistics annually. Their joint report highlights data related to important modifiable risk factors affecting cardiovascular health and outcomes associated with the quality of care, procedures, and economic costs for cardiovascular-related conditions.
The AHA Council on Epidemiology and Prevention Statistics Committee and Stroke Statistics Subcommittee recently published “The Heart Disease and Stroke Statistics — 2022 Update: A Report From the American Heart Association” in the AHA’s peer-reviewed journal Circulation.
According to 2020 Global Burden of Disease (GBD) study data, the number of people worldwide with Alzheimer’s disease and related dementias increased at a greater rate than that of people with ischemic heart disease (IHD). From 1990 to 2020, the prevalence of Alzheimer’s disease and related dementias increased about 144{cfdf3f5372635aeb15fd3e2aecc7cb5d7150695e02bd72e0a44f1581164ad809} globally, compared with 120{cfdf3f5372635aeb15fd3e2aecc7cb5d7150695e02bd72e0a44f1581164ad809} for IHD.
The study reports more dramatic differences in Alzheimer’s disease and related dementias death rates during the same time frame, with an approximately 185{cfdf3f5372635aeb15fd3e2aecc7cb5d7150695e02bd72e0a44f1581164ad809} increase in Alzheimer’s disease and related dementias deaths and a 66{cfdf3f5372635aeb15fd3e2aecc7cb5d7150695e02bd72e0a44f1581164ad809} increase in IHD-related deaths.
A systematic analysis of the 2017 GBD study — the most recent data available — reports that 2.9 million people in the United States had an Alzheimer’s disease or Alzheimer’s disease and related dementias diagnosis.
It is the fourth most prevalent neurological disorder in the U.S., as well as the leading cause of death from neurological disease, surpassing stroke.
There is also a significant economic burden associated with Alzheimer’s disease and related dementias. Between 1996 and 2016, U.S. spending on dementias increased twofold, from about $39 billion to $79 billion.
Dr. Mitchell Elkind, the immediate past president of the AHA, a professor of neurology and epidemiology at Columbia University Vagelos College of Physicians and Surgeons, and attending neurologist at New York-Presbyterian/Columbia University Irving Medical Center in New York, spoke with Medical News Today about the new updates.
“Heart disease and brain disease share many of the same risk factors. Cardiovascular disease risk factors, or the health behaviors and conditions that can lead to heart attacks, include high blood pressure, diabetes, smoking, high cholesterol, and obesity,” he explained.
“For some time, we have known that these same risk factors also lead to strokes, which are injuries to the brain caused by blood vessel — i.e., vascular — disorders. What clinicians, epidemiologists, and other scientists have more recently found is that these same risk factors also contribute to other manifestations of brain disease, such as cognitive decline and dementia, that had not previously been recognized as [a] vascular disorder.”
– Dr. Mitchell Elkind
The 2022 Update highlights the effects of cardiovascular disease risk factors on cognitive dysfunction or dementia development.
In brief, a meta-analysis of 139 studies demonstrated that people with high blood pressure midlife were 55{cfdf3f5372635aeb15fd3e2aecc7cb5d7150695e02bd72e0a44f1581164ad809} more likely to develop impaired global cognition and about 20{cfdf3f5372635aeb15fd3e2aecc7cb5d7150695e02bd72e0a44f1581164ad809} more likely to experience impaired executive function, dementia, or Alzheimer’s disease.
Another meta-analysis of four studies found that people with heart failure were 80{cfdf3f5372635aeb15fd3e2aecc7cb5d7150695e02bd72e0a44f1581164ad809} more likely to develop dementia, while a meta-analysis of 14 studies found that females with diabetes had a 62{cfdf3f5372635aeb15fd3e2aecc7cb5d7150695e02bd72e0a44f1581164ad809} higher risk of developing dementia, and males had a 58{cfdf3f5372635aeb15fd3e2aecc7cb5d7150695e02bd72e0a44f1581164ad809} higher risk.
In terms of the risk of dementia linked to obesity, a meta-analysis of studies with up to 42 years of follow-up showed that people with midlife obesity had a 33{cfdf3f5372635aeb15fd3e2aecc7cb5d7150695e02bd72e0a44f1581164ad809} increased risk of developing dementia.
Smoking also remains an important risk factor. A meta-analysis of 37 studies demonstrated that people who smoked at the time had a 30{cfdf3f5372635aeb15fd3e2aecc7cb5d7150695e02bd72e0a44f1581164ad809} increased risk of dementia, a 40{cfdf3f5372635aeb15fd3e2aecc7cb5d7150695e02bd72e0a44f1581164ad809} higher risk of Alzheimer’s disease, and a 38{cfdf3f5372635aeb15fd3e2aecc7cb5d7150695e02bd72e0a44f1581164ad809} increased risk of vascular dementia.
The risk of cognitive dysfunction or dementia can vary depending on race, ethnicity, sex, education, occupation, and geography.
The 2022 Update highlights an analysis of 2016 Behavioral Risk Factor Surveillance System data that showed that Black adults were about three times more likely and Hispanic adults about four times more likely than white adults to need assistance with daily activities due to memory loss.
Additionally, Alzheimer’s disease and related dementias disproportionately affects females. According to GBD data from 2020, about 20 million males and 35 million females worldwide had a diagnosis of Alzheimer’s disease and related dementias, with a death rate of 1.28 million for females and 0.61 million for males.
Dr. Elkind commented:
“Because nearly half of all adults in the U.S. have elevated blood pressure, and 40{cfdf3f5372635aeb15fd3e2aecc7cb5d7150695e02bd72e0a44f1581164ad809} are obese, these data provide an inkling of what we can expect to see in the future as the population ages, and the impact of these risk factors begins to be felt. Recent data suggest that globally, dementia cases may triple over the next 3 decades, even as heart disease declines.”
Decreasing risk by modifying lifestyles and behavioral risk factors may help protect people from developing cardiovascular disease, stroke, and dementia. Dr. Elkind stated that a system-wide approach is necessary to achieve long-term behavioral change.
He explained: “Researchers are now testing technologies to see if they can improve our success rates with behavioral risk factors; some of these approaches involve moving the focus of care from the doctor’s office to the home and involving nonphysician providers in management to improve efficiency. For example, can in-home blood pressure monitoring with real-time connection to a doctor or nurse help improve blood pressure?”
Dr. Elkind also wondered: “Can we use nonclinical settings, such as barbershops, to reach Black men and women to detect high blood pressure and make changes in their lifestyles? […] These types of approaches may ultimately lead to bigger benefits than doctors prescribing specific medications or trying to convince individual patients to change their behaviors.”
Dr. Jason Tarpley — a stroke neurologist and director of the Stroke and Neurovascular Center for Pacific Neuroscience Institute at Providence Saint John’s Health Center in Santa Monica, CA — went on to comment, in an interview with MNT, that “the take-home message is that a lot of this is preventable” through a combination of a healthy diet, exercise, and medications.
He added: “The information age is helping people […] [P]atients know their cholesterol number, they know their LDL, they know their hemoglobin A1C — which is a long-term measurement of their blood sugar — and they know [their] blood pressures. I […] see that behaviors are changing, and I think that people are […] taking more their health into their own hands, and that’s really good.”
Share on PinterestNew study indicates that a substantial proportion of noted facet outcomes from COVID-19 vaccines might be down to a so-called “nocebo effect.” Jens Schlueter/Getty Visuals
When placebos elicit adverse functions, these are generally identified as nocebo responses.
A examine finds that a 3rd of persons who gained placebos all through COVID-19 vaccine scientific trials described uncomfortable systemic aspect consequences these kinds of as headache and fatigue.
The authors of the research find that 76{cfdf3f5372635aeb15fd3e2aecc7cb5d7150695e02bd72e0a44f1581164ad809} of facet consequences reported by actual vaccine recipients are very likely the same consequences and attributable to nocebo responses.
It is nicely-acknowledged that a “placebo” is a substance with no health care outcomes, usually employed as a handle in testing new prescription drugs. The placebo might be a further compound or some thing that ought to have no affect. Considering that members do not know whether or not they bought the substance scientists are tests or a placebo, the scientists can greater belief the reliability of documented effects.
Recent research, however, has demonstrated that trial members who have gained a placebo might nonetheless genuinely encounter the effect of the real material, even if they know that they gained a placebo.
This is known as the “placebo influence.” It is not but totally comprehended why this transpires, but the placebo outcomes can supply true health-related advantages, together with to people today with irritable bowel syndrome and chronic ache. Nonetheless, there is also evidence of an affiliation among placebos and unpleasant adverse reactions or adverse activities (AEs).
A new study finds that 35.2{cfdf3f5372635aeb15fd3e2aecc7cb5d7150695e02bd72e0a44f1581164ad809} of demo members who received inert saline option placebos rather of a COVID-19 vaccine in trials documented at the very least a single adverse response.
Some of these AEs were being regional, this sort of as soreness at the injection web page. Many others, these kinds of as complications and fatigue, were being systemic and unforeseen from a harmless saline injection.
The percentage of vaccine-getting members who also reported placebo-centered indicators demonstrated what is recognised as a nocebo response.
Dr. Erica Smith — who was not involved in the examine — works for Cognivia, a business that can help scientists deal with placebo responses in scientific trials. She instructed Healthcare Information Nowadays:
“The conclusions of this examine — that a considerable proportion of adverse gatherings described in medical trials for COVID-19 vaccines are unrelated to the treatment method by itself and are alternatively attributable to the nocebo outcome — can and should be leveraged by the professional medical community with the hopes of expanding vaccine acceptance.”
Among contributors who gained an genuine COVID-19 vaccine, 76{cfdf3f5372635aeb15fd3e2aecc7cb5d7150695e02bd72e0a44f1581164ad809} of systemic AEs right after the initially vaccination were being attributable to the nocebo reaction alternatively than the vaccine itself.
Dr. Julia Haas, an investigator in the placebo reports method at Beth Israel Deaconess Medical Centre (BIDMC), led the study. Dr. Haas made available Health care News These days a specific description of how her team arrived at the 76{cfdf3f5372635aeb15fd3e2aecc7cb5d7150695e02bd72e0a44f1581164ad809} figure and why they regarded such AEs nocebos:
“We believe that all the effects that guide to uncomfortable signs and symptoms following placebo treatment method are also apparent when you get the true vaccine. We located that 35{cfdf3f5372635aeb15fd3e2aecc7cb5d7150695e02bd72e0a44f1581164ad809} of placebo recipients documented systemic [AEs], i.e., signs like headache or tiredness.”
“This range is a few-quarters as superior as the variety of vaccine recipients with such signs and symptoms (46{cfdf3f5372635aeb15fd3e2aecc7cb5d7150695e02bd72e0a44f1581164ad809} claimed systemic adverse gatherings, [and 35 is 76{cfdf3f5372635aeb15fd3e2aecc7cb5d7150695e02bd72e0a44f1581164ad809} of 46]). This implies three-quarters of the systemic indications vaccine recipients expertise are not because of to the vaccine itself but would have also transpired if they experienced acquired a placebo. This is the nocebo response.”
“The high range of nocebo responses identified in this examine [is] not at all astonishing,” mentioned Dr. Smith. “It is well-identified that expectation contributes considerably to each placebo and nocebo responses in scientific trials.”
Dr. Smith stated that at Cognivia, “we have appear to comprehend that expectation is alone multidimensional, as there are different varieties of expectation — such as hope and will need — that must be regarded.”
For second doses of vaccines, reported AEs went up from 46{cfdf3f5372635aeb15fd3e2aecc7cb5d7150695e02bd72e0a44f1581164ad809} to 61{cfdf3f5372635aeb15fd3e2aecc7cb5d7150695e02bd72e0a44f1581164ad809}, when AEs for placebo recipients lowered from 35{cfdf3f5372635aeb15fd3e2aecc7cb5d7150695e02bd72e0a44f1581164ad809} to 32{cfdf3f5372635aeb15fd3e2aecc7cb5d7150695e02bd72e0a44f1581164ad809}.
The authors speculate that the enhance for vaccine recipients may possibly relate to their experiences with AEs following the 1st shot.
Dr. Haas proposed that adverse anticipations may perhaps occur from “other men and women who explained they experienced facet effects, previous knowledge with side outcomes of other vaccines or prescription drugs, panic or unspecific problems, and the conduct of the clinician, e.g., [do they] present heat, empathy, competence?”
“Furthermore,” noted Dr. Haas, “misattribution of indicators may participate in a position.”
“This,” claimed Dr. Haas, “means that you most likely have complications routinely, but if you have a headache the day right after the vaccine or placebo shot, you consider it was prompted by the injection, whilst it may possibly have happened in any case.”
“Medicine is primarily based on believe in. Our results lead us to recommend that informing the general public about the potential for nocebo responses could help reduce worries about COVID-19 vaccination, which could possibly lower vaccination hesitancy.”
Dr. Smith pointed out a different explanation:
“In clinical follow, open up-label placebos have the prospective to give actual therapeutic gains to some individuals — in particular for situations like serious pain, Parkinson’s ailment, and depression.”
For are living updates on the newest developments relating to the novel coronavirus and COVID-19, simply click here.
Restrictions and uncertainties brought on by COVID-19 have made it necessary to reconsider many of the day-to-day aspects of life. Contending with these on top of preexisting everyday decisions has led many to feel what is known as “decision fatigue.”
Share on PinterestWhat is decision fatigue, and how has this phenomenon evolved during the COVID-19 pandemic? David Espejo/Getty Images.
Decision fatigue happens when, after making many decisions at once, a person’s ability to make decisions declines. Complex decisions, such as those posed by the COVID-19 pandemic, deplete one’s capacity for decision making especially quickly.
According to a survey by the American Psychological Association published in October 2021, 32{cfdf3f5372635aeb15fd3e2aecc7cb5d7150695e02bd72e0a44f1581164ad809} of adults in the United States struggled to make basic decisions, such as what to wear, due to COVID-19-induced stress.
Different age groups reported experiencing the phenomenon at different rates:
48{cfdf3f5372635aeb15fd3e2aecc7cb5d7150695e02bd72e0a44f1581164ad809} of millennials
37{cfdf3f5372635aeb15fd3e2aecc7cb5d7150695e02bd72e0a44f1581164ad809} of Generation Z
32{cfdf3f5372635aeb15fd3e2aecc7cb5d7150695e02bd72e0a44f1581164ad809} of Generation X
14{cfdf3f5372635aeb15fd3e2aecc7cb5d7150695e02bd72e0a44f1581164ad809} of baby boomers
3{cfdf3f5372635aeb15fd3e2aecc7cb5d7150695e02bd72e0a44f1581164ad809} of older adults
These findings correspond with the survey’s findings on stress levels. Younger groups were significantly more likely to report high stress levels than older groups.
Parents with children under 18 years old were also disproportionately affected by stress compared with those without children. While 47{cfdf3f5372635aeb15fd3e2aecc7cb5d7150695e02bd72e0a44f1581164ad809} of these parents reported that day-to-day decisions were more stressful than before the pandemic, the same was true for 30{cfdf3f5372635aeb15fd3e2aecc7cb5d7150695e02bd72e0a44f1581164ad809} of those without children under 18 years old.
People of Color have also been more affected by pandemic-related stress. According to the study, 38{cfdf3f5372635aeb15fd3e2aecc7cb5d7150695e02bd72e0a44f1581164ad809} of Hispanic adults and 36{cfdf3f5372635aeb15fd3e2aecc7cb5d7150695e02bd72e0a44f1581164ad809} of Black adults reported that pandemic-related stress impacted their decision making, compared with 29{cfdf3f5372635aeb15fd3e2aecc7cb5d7150695e02bd72e0a44f1581164ad809} of non-Hispanic White adults.
Decision fatigue happens when a person becomes fatigued or exhausted from making too many decisions. It affects a person’s ability to make further decisions, whether simple, such as deciding what to eat for dinner, or complex, such as determining whether or not to change jobs.
The concept of decision fatigue originated in 1998. It centers on the idea that humans have a limited capacity to regulate their behavior.
This means that after a certain point, people simply run out of energy to make decisions, much like a car running out of fuel once its petrol tank is empty. Running out of “decision making fuel” is also known as ego depletion.
Ego depletion changes the way we focus on and process information to make decisions, as well as our motivations. These motivational shifts can make a person more likely to make impulsive decisions that, under normal circumstances, they would not make.
“Doing repeated decision making [that] involves trade-offs between multiple competing values, such as risks and benefits” increases a person’s risk of experiencing decision fatigue, Dr. Gustav Tinghög, an associate professor at Linkoping University in Sweden, told Medical News Today.
“Careful consideration of pros and cons in decision making is mentally taxing and may lead to decision fatigue when we feel stressed and mentally overloaded. This can lead people to shy away from engaging in cognitively demanding reasoning when tired and instead turn to decision‐making heuristics, that is, mental shortcuts that allow us to make decisions on the basis of simple rules of thumb without engaging in cognitively demanding reasoning.”
– Dr. Gustav Tinghög
But decision fatigue does not just happen from making decisions. It can happen from any activity that demands the exertion of self-control.
Dr. Grant A. Pignatiello, an instructor and clinical research scholar at Case Western Reserve University in Cleveland, told MNT that “[d]ecision fatigue can manifest after repeated or effortful attempts of self-control.”
“The most common example is from making decisions. But it can also result from controlling your emotions, doing things that require cognitive effort, or intense physical exertion,” he noted.
Several factors are associated with a higher risk of decision fatigue, including:
Dr. Pignatiello said that everyone is susceptible to decision fatigue. However, the exact causes will differ from person to person:
“It’s important to know that the circumstances that lead to decision fatigue are unique for every person — for example, two individuals doing the same thing may experience different levels of decision fatigue. For a literal example, running a 5K may deplete your tank more than it would a person who runs every day.”
He added that the demands of modern everyday life, alongside modern work environments, necessitate complicated decisions that may make some more susceptible to decision fatigue than others.
There have not been many studies exploring the direct impacts of COVID-19 on decision fatigue. However, as research has shown that mental health generally deteriorated at the beginning of the pandemic, it is possible that rates of decision fatigue increased too.
“I’m unaware of any data that examined the pandemic’s unique contribution to decision fatigue,” said Dr. Pignatiello. “However, […] our day-to-day lives are further complicated by decisions about where to go, who to see, and how to spend our time.”
“Also, our work environments have changed dramatically — most of us have needed to adapt to working at home, healthcare workers are burnt out from the intense demand placed upon healthcare systems, and many have flat-out lost their jobs. All of these things in [themselves] can be stressful,” he explained.
“Simply put, living in society has become much more complex, and we have had to adapt to these complexities very suddenly. These complexities have introduced new problems that have required more effort to deal with than we are used to,” he continued.
However, how long any knock-on effects of deteriorating mental health on decision fatigue persist is debatable without further research. Studies have found that negative impacts on emotions and mental health tended to subside after the initial months of the pandemic. The same may thus be true for decision fatigue.
Nevertheless, the impact of decision fatigue on healthcare workers — especially nurses — may have lingered beyond the first few months of the pandemic. A commentary published in September 2021 cautioned that healthcare organizations should provide facilities for nurses to prevent decision fatigue arising from COVID-19-related strain on healthcare systems.
Another study from last year validated an instrument to assess whether nurses were experiencing decision fatigue. They found that decision fatigue scores were strongly correlated with traumatic stress and moderately correlated with the nursing practice environment.
“In the healthcare context, medical staff in many areas are under a lot of pressure and engage in difficult repeated decision making that is likely to deplete their mental resources, which in turn impairs subsequent reasoning and makes them more prone to make decisions based on the most prominent value,” said Dr. Tinghög.
“Health care priority setting typically involves trade-offs that pit the lives and well-being of some individuals against the lives and well-being of more distant others. People are inherently bad at weighing valued objectives against each other and instead base choice on the emotionally most prominent value,” he added.
“That is the most defensible value. This is problematic because it means that opportunity costs are likely to be neglected in health care priority setting as a consequence of decision fatigue.”
– Dr. Gustav Tinghög
Signs of decision fatigue include brain fog, feeling tired, and other signs of physical or mental fatigue. These may intensify the more decisions a person makes throughout the day.
When asked how people may be able to spot whether or not they are experiencing decision fatigue, Dr. Tinghög said, “If there are drifts in the type of decision you are making throughout the day, without there being a logical explanation, this could be due to decision fatigue.”
“But also, it is possible to identify decision fatigue through introspection,” he added. “When we feel that we don’t have enough mental energy to make a thorough deliberation before an important decision, we are suffering from decision fatigue.”
Dr. Pignatiello also noted:
“It requires some self-awareness for us to know when we may be in a state of decision fatigue. Some common signs include struggling with decisions that otherwise would not require much thought, e.g., ‘What do I eat for dinner?’ ‘What should I wear?’, feeling overwhelmed by our emotions, having a harder time remembering things or focusing, or simply just feeling more ‘drained’ than normal.”
When MNT asked how a person can overcome decision fatigue, Dr. Pignatiello highlighted three ways to either “refill our tank” or use our so-called decision making fuel more efficiently.
In his words, these are:
Eliminate the mundane decisions in your life so you can use your energy for decisions that require more thought. This can be as simple as planning out your outfits, meal prepping so you have left overs, and establishing daily routines.
Be compassionate to yourself. If you need time and space to refill your tank, do it. Take that nap, watch that new episode, read your new mystery book. If you find it replenishing for your mind and body, do it.
Take care of yourself — make sure you’re getting enough sleep. My work has shown that sleep problems and decision fatigue are related to one another. Eat healthy, take care of your body by exercising, find healthy outlets for your stress, etc.
Dr. Tinghög added three more points to bear in mind:
Advise someone you trust to check your thinking. Deliberation with other[s] often relives some anxiety related to decision making.
Don’t let the fear of making the wrong decision paralyze you. Making a good enough decision is often good enough. Not every decision needs to be perfect. Remind yourself that most decisions are revokable if something goes wrong.
Review your past decisions, not all the time but with some regularity. Identify cases of poor decision making and try to understand why it came about. This might be good to detect where decision fatigue has affected your behavior and learn from it […].
